3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
28
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
7
Multiple Myeloma
6
Hematologic Neoplasms
6
Neoplasm Metastasis
4
Lymphoma
4
Leukemia, Myeloid, Acute
3
Colorectal Neoplasms
3
Brain Neoplasms
3
Biliary Tract Neoplasms
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Glioma
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Adenocarcinoma, Follicular
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
fludarabine phosphate
16
Peripheral Blood Stem Cell Transplantation
16
Cyclophosphamide
16
Mycophenolic Acid
14
Whole-Body Irradiation
13
Cyclosporine
12
Busulfan
12
Tacrolimus
11
Methotrexate
10
Antilymphocyte Serum
9
Etoposide
7
Cyclosporins
7
Melphalan
6
Sirolimus
5
Radiotherapy
5
Cytarabine
5
Filgrastim
4
Cord Blood Stem Cell Transplantation
4
ruxolitinib
3
Rituximab
3
Granulocyte Colony-Stimulating Factor
3
Alemtuzumab
3
thymoglobulin
2
sargramostim
2
Pentostatin
2
Methylprednisolone
2
Flow Cytometry
2
Carmustine
2
Carboplatin
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myelodysplastic-Myeloproliferative Diseases
×
trametinib
×
Clear all
No trials found.